Skip to content
Lower risk Drug recall · FDA · Published October 12, 2021

BRP Pharmaceuticals Recalls Methocarbamol 500mg Tablets Due to Strength Label Error

BRP Pharmaceuticals recalls methocarbamol tablets labeled as 500mg but containing 750mg due to labeling error. Consumers should check product details and contact the company for guidance.

🇺🇸 FDA recall #D-0092-2022DrugBRP Pharmaceuticals ›
Take action

Contact the company

Recalling firmBryant Ranch Prepack, Inc. dba BRP Pharmaceuticals1919 N Victory Pl · Burbank, CA 91504-3425
✎ GovInfoNow plain-language explainer

What happened, in plain English

BRP Pharmaceuticals has recalled methocarbamol tablets that are labeled as 500mg but actually contain 750mg. This labeling error could lead to incorrect dosing and potential health risks if taken without knowing the actual strength. Read more at govinfonow.com/recall/35785-brp-pharmaceuticals-recalls-methocarbamol-500mg-tablets-due-to-strength-label.

Source Summary by GovInfoNow · govinfonow.com/recall/35785-brp-pharmaceuticals-recalls-methocarbamol-500mg-tablets-due-to-strength-label · Updated August 18, 2026 · FDA enforcement record: FDA #D-0092-2022

Cite this page

“BRP Pharmaceuticals Recalls Methocarbamol 500mg Tablets Due to Strength Label Error.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35785-brp-pharmaceuticals-recalls-methocarbamol-500mg-tablets-due-to-strength-label. Based on FDA recall #D-0092-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0092-2022%22&limit=1).

Why it’s dangerous

The tablets are labeled as 500mg but contain 750mg, which could result in an overdose if taken as directed. This labeling error may cause incorrect dosing and health risks, especially for those using the medication for conditions like muscle spasms or seizures.

Who’s affected

People who have purchased the recalled methocarbamol tablets from pharmacies or retailers. Those using the medication for muscle spasms or seizures are most at risk due to potential incorrect dosing.

How to tell if you have this one

Check for bottles labeled as Methocarbamol 500mg Tablets with NDC numbers 7133517952 (30 count), 7133517954 (60 count), or 7133517957 (90 count). The product is prescription-only and was packaged by Bryant Ranch Prepack in Burbank, CA.

  • Brand
    BRP Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC number on the bottle to confirm if it matches the recalled numbers: 7133517952, 7133517954, or 7133517957.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 29 days after the firm started it.

1. Firm started the recall: Oct 12, 202112. FDA classified it Class I: Nov 2, 202123. Published in FDA’s Enforcement Report: Nov 10, 202132021
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0092-2022 (October 12, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0092-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA